New Key Statistics Module, Z-Score and F-Score
NAS:PTGX Key Ratios
| Market Cap $ M | 7,949.53 |
| Enterprise Value $ M | 7,411.52 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | 27.89 |
| Price/Book | 12.11 |
| Price/Sales | 114.78 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 74.00 |
| EPS (TTM) $ | -1.81 |
| Beneish M-Score | 0.9 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -811.30 |
| EV-to-EBIT | -52.02 |
| EV-to-EBITDA | -52.56 |
| PEG | -- |
| Shares Outstanding M | 64.31 |
| Net Margin (%) | -154.88 |
| Operating Margin % | -192.36 |
| Pre-tax Margin (%) | -155.78 |
| Quick Ratio | 17.76 |
| Current Ratio | 17.76 |
| ROA % (ttm) | -16.26 |
| ROE % (ttm) | -17.53 |
| ROIC % (ttm) | -104.55 |
| Dividend Yield % | -- |
| Altman Z-Score | 108.88 |
PTGX Number of Guru Trades
PTGX Volume of Guru Trades
Gurus Latest Trades with NAS:PTGX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:PTGX is held by these investors
Total 4
Protagonist Therapeutics Inc Insider Transactions
No Available Data
News about NAS:PTGX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers